View Document Preview and Link Document Date: 2014-03-15 02:35:44 Open Document File Size: 80,78 KB Share Result on Facebook
Company Provincial Laboratory / Merck / Emedicine / / Continent Africa / North America / / Country Nepal / Myanmar / Bangladesh / Mozambique / Egypt / Indonesia / United States / Brazil / Canada / Nigeria / China / Philippines / Madagascar / Papua New Guinea / India / Sierra Leone / / Facility Provincial Laboratory / / IndustryTerm bacteriologic media / / MedicalCondition Hansen’s disease / Harrop E. Leprosy / Kain K. Leprosy / Indeterminate leprosy / erythema nodosum leprosum / Notifiable Diseases / iritis / lepromatous disease / bone resorption / Infections / infectious case / highly endemic disease / keratitis / epistaxis / For tuberculoid leprosy / lepromatous leprosy / Borderline leprosy / disease / Naturally acquired disease / Probable Case Clinical illness / active untreated disease / Tuberculoid leprosy / Clinical illness / chronic disease / lepramatous leprosy / infectious diseases / infection / curable disease / leprosy / human disease / / MedicalTreatment drug therapy / Antibiotic therapy / / NaturalFeature Sierra Leone / / Organization World Health Organization / Public Health Agency of Canada / Government of Alberta / / Position Occurrence General / Attending/ordering physician / infectious diseases specialist / Chief Medical Officer / Medical Officer / infectious diseases physician / attending physician / / Product rifampin / dapsone / / ProvinceOrState Alberta / Texas / Louisiana / Hawaii / California / / Region Latin America / South Asia / Southeast Asia / / URL http / SocialTag 
Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August[removed]Leprosy